Serotonin 2c receptor RNA editing in major depression and suicide

World Journal of Biological Psychiatry

Volumn 14, Issue 8, 2013, Pages 590-601

  Lyddon, Rebecca ^a,b   Dwork, Andrew J ^c,d,e   Keddache, Mehdi ^f   Siever, Larry J ^a,b   Dracheva, Stella ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

ADAR; Major depressive disorder; RNA editing; Serotonin receptor; Suicide

Indexed keywords

ADAR1 PROTEIN; ADAR2 PROTEIN; ADENOSINE DEAMINASE; MESSENGER RNA; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREFRONTAL CORTEX; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA EDITING; SEQUENCE ANALYSIS; SUICIDE;

ADENOSINE DEAMINASE; ADULT; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; SEQUENCE ANALYSIS, RNA; SUICIDE; TISSUE BANKS;

EID: 84887917625     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.630406     Document Type: Article

References (56)

1. Abbas AI, Urban DJ, Jensen N.H., Farrell MS, Kroeze WK, Mieczkowski P, et al. 2010. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res 38:e118.
2. Akbarian S. 2008. Approaching the molecular pathology of suicide. Biol Psychiatry 64: 643-644.
3. Bagdy G, Graf M, Anheuer Z.E., Modos EA, Kantor S. 2001. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4: 399-408. (Pubitemid 33151684)
4. Bass BL. 2002. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71: 817-846. (Pubitemid 34800236)
5. Berg KA, Cropper JD, Niswender C.M., Sanders-Bush E, Emeson RB, Clarke WP. 2001. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134: 386-392. (Pubitemid 32989136)
6. Boldrini M, Underwood MD, Hen R, Rosoklija G.B., Dwork AJ, John MJ, et al. 2009. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34: 2376-2389.
7. Bristow LJ, O'Connor D, Watts R, Duxon M.S., Hutson PH. 2000. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Neuropharmacology 39: 1222-1236. (Pubitemid 30173186)
8. Burns CM, Chu H, Rueter S.M., Hutchinson LK, Canton H, Sanders-Bush E, et al. 1997. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303-308. (Pubitemid 27220768)
9. Canton H, Emeson RB, Barker E.L., Backstrom JR, Lu JT, Chang MS, et al. 1996. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 50: 799-807. (Pubitemid 26347699)
10. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. 2003. Psychological autopsy studies of suicide: a systematic review. Psychol Med 33: 395-405. (Pubitemid 36442783)
11. Chanrion B, Mannoury la CC, Gavarini S, Seimandi M, Vincent L., Pujol JF, et al. 2008. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol 73: 748-757.
12. Chen B, Dowlatshahi D, MacQueen G.M., Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50: 260-265. (Pubitemid 32778442)
13. Di Giovanni G., De Deurwaerdere P, Di Mascio M, Di M, V, Esposito E, Spampinato U. 1999. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91: 587-597. (Pubitemid 29193268)
14. Di M, V, Cacchio M, Di GC, Di GG, Esposito E. 2002. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Pharmacol Biochem Behav 71: 607-613. (Pubitemid 34219211)
15. Dracheva S, Lyddon R, Barley K., Marcus SM, Hurd YL, Byne WM. 2009. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 34: 2237-2251.
16. Dracheva S, Patel N, Woo D.A., Marcus SM, Siever LJ, Haroutunian V. 2008. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry 13: 1001-1010.
17. Du Y, Davisson MT, Kafadar K, Gardiner K. 2006. A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons among inbred mouse strains. Gene 382: 39-46. (Pubitemid 44548253)
18. Enstero M, Daniel C, Wahlstedt H., Major F, Ohman M. 2009. Recognition and coupling of A-to-I edited sites are determined by the tertiary structure of the RNA. Nucleic Acids Res 37: 6916-6926.
19. Ernst C, Mechawar N, Turecki G. 2009. Suicide neurobiology. Prog Neurobiol 89: 315-333.
20. Esposito E. 2006. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets 7: 177-185.
21. Fitzgerald LW, Iyer G, Conklin D.S., Krause CM, Marshall A, Patterson JP, et al. 1999. Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21: 82-90S.
22. Flomen R, Knight J, Sham P., Kerwin R, Makoff A. 2004. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res 32: 2113-2122. (Pubitemid 38864685)
23. Gatch MB. 2003. Discriminative stimulus effects of m- chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73: 1347-1367. (Pubitemid 36798125)
24. Gott JM, Emeson RB. 2000. Functions and mechanisms of RNA editing. Annu Rev Genet 34: 499-531. (Pubitemid 32065931)
25. Gurevich I, Tamir H, Arango V., Dwork AJ, Mann JJ, Schmauss C. 2002. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34: 349-356. (Pubitemid 34465494)
26. Hartner JC, Schmittwolf C, Kispert A., Muller AM, Higuchi M, Seeburg PH. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279: 4894-4902. (Pubitemid 38199085)
27. Hawton K, Van Heeringen K. 2009. Suicide. Lancet 373: 1372-1381.
28. Herrick-Davis K., Grinde E, Niswender CM. 1999. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73: 1711-1717. (Pubitemid 29440175)
29. Higuchi M, Maas S, Single F.N., Hartner J., Rozov A, Burnashev N, et al. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406: 78-81. (Pubitemid 30460214)
30. Iwamoto K, Kato T. 2003. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 346: 169-172. (Pubitemid 36829288)
31. Kenward MG, Roger JH. 1997. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53: 983-997. (Pubitemid 27391027)
32. Lance CE (2005). Mallows' Cp Statistics. In: Everitt BS, Howell DC, editors. Encyclopedia of statistics in behavioral science. Chichester: John Wiley & Sons. p. 1119-1120.
33. Mann JJ. 2003. Neurobiology of suicidal behaviour. Nat Rev Neurosci 4: 819-828. (Pubitemid 37314404)
34. Mann JJ, Huang YY, Underwood M.D., Kassir SA, Oppenheim S, Kelly TM, et al. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-738. (Pubitemid 30650106)
35. Mann JJ, Arango VA, Avenevoli S, Brent D.A., Champagne FA, Clayton P, et al. 2009. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 65: 556-563.
36. Marion S, Weiner DM, Caron MG. 2004. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 279: 2945-2954. (Pubitemid 38114287)
37. Millan MJ. 2005. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60: 441-460.
38. Morabito MV, Ulbricht RJ, O'Neil RT, Airey DC, Lu P, Zhang B., et al. 2010. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol 77: 895-902.
39. Moreno FA, Rowe DC, Kaiser B, Chase D., Michaels T, Gelernter J, et al. 2002. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7: 213-216. (Pubitemid 34177790)
40. Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
41. Niswender CM, Copeland SC, Herrick-Davis K, Emeson R.B., Sanders-Bush E. 1999. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274: 9472-9478.
42. Niswender CM, Herrick-Davis K, Dilley G.E., Meltzer HY, Overholser JC, Stockmeier CA, et al. 2001. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24: 478-491. (Pubitemid 32244309)
43. Palvimaki EP, Roth BL, Majasuo H, Laakso A., Kuoppamaki M, Syvalahti E, et al. 1996. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berlin) 126: 234-240. (Pubitemid 26252760)
44. Pandey GN, Dwivedi Y, Ren X., Rizavi HS, Roberts RC, Conley RR. 2007. Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol 10: 621-629. (Pubitemid 47517519)
45. Quirk K, Lawrence A, Jones J., Misra A, Harvey V, Lamb H., et al. 2001. Characterisation of agonist binding on human 5-HT2C receptor isoforms. Eur J Pharmacol 419: 107-112. (Pubitemid 32568208)
46. Serretti A, Artioli P, De Ronchi D. 2004. The 5-HT2C receptor as a target for mood disorders. Expert Opin Ther Targets 8: 15-23. (Pubitemid 38240021)
47. Simmons M, Meador-Woodruff JH, Sodhi MS. 2010. Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. NeuroReport 21: 993-997.
48. Smith KA, Fairburn CG, Cowen PJ. 1997. Relapse of depression after rapid depletion of tryptophan. Lancet 349: 915-919. (Pubitemid 27139821)
49. Sodhi MS, Airey DC, Lambert W, Burnet P.W., Harrison PJ, Sanders-Bush E. 2005. A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol 68: 711-719. (Pubitemid 41206024)
50. Tohda M, Hang PT, Kobayashi N, Matsumoto K. 2010. Serotonin 2C receptor (5-HT2CR) mRNA editing-induced downregulation of 5-HT2CR function in Xenopus oocytes: the significance of site C editing. J Pharmacol Sci 113: 362-367.
51. Torrey EF, Webster M, Knable M., Johnston N, Yolken RH. 2000. The stanley foundation brain collection and neuropathology consortium 1. Schizophr Res 44: 151-155. (Pubitemid 30411930)
52. Valente L, Nishikura K. 2005. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 79: 299-338. (Pubitemid 43574881)
53. Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F., Cavaille J, et al. 2005. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol 169: 745-753. (Pubitemid 41002880)
54. Wang Q, Khillan J, Gadue P., Nishikura K. 2000a. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290: 1765-1768. (Pubitemid 32004807)
55. Wang Q, O'Brien PJ, Chen CX, Cho D.S., Murray JM, Nishikura K. 2000b. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 74: 1290-1300. (Pubitemid 30104328)
56. Werry TD, Loiacono R, Sexton P.M., Christopoulos A. 2008. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119: 7-23.